- Home
- / Apollo Endosurgery
Apollo Endosurgery
Revenue
$76.9 M
FY, 2022
Apollo Endosurgery Summary
Company Summary
- Overview
- Apollo Endosurgery is a medical technology company that focuses on the development of invasive devices for therapeutic endoscopy. Its device-based therapies include endoscopic sleeve gastroplasty, gastric balloon, transoral outlet reduction, etc.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2005
- HQ
- Austin, TX, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Christopher J. Gostout, Chief Medical Officer
David Hooper, Vice President, Quality and Regulatory Affairs
John Molesphini, Executive Vice President, Operations
LocationsView all
3 locations detected
Austin, TX HQ
United States
1120 S. Capital of Texas Highway, Building 1, Suite 300
Alajuela, Provincia de Alajuela
Costa Rica
Coyol Free Zone Alajuela, Provincia de Alajuela
Hemel Hempstead, England
United Kingdom
Breakspear Park, Breakspear Way
Apollo Endosurgery Financials
Summary Financials
- Revenue (FY, 2022)
- $76.9M
- Gross profit (FY, 2022)
- $42.4M
- Net income (FY, 2022)
- ($39.8M)
- Cash (FY, 2022)
- $57.0M
- EBIT (FY, 2022)
- ($31.4M)